ZYNERBA PHARMACEUTICALS, INC. Lease, Cost
ZYNERBA PHARMACEUTICALS, INC. reported Lease, Cost of $160.95 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2023-08-14
- ZYNERBA PHARMACEUTICALS, INC. lease, cost for the quarter ending 2023-06-30 was $75.09K, a 0.00% change year-over-year.
- ZYNERBA PHARMACEUTICALS, INC. lease, cost for the quarter ending 2023-03-31 was $85.85K, a 10.03% increase year-over-year.
- ZYNERBA PHARMACEUTICALS, INC. lease, cost for the quarter ending 2022-12-31 was $75.09K, a 0.00% change year-over-year.
- ZYNERBA PHARMACEUTICALS, INC. lease, cost for the quarter ending 2022-09-30 was $75.09K, a 0.00% decline year-over-year.
- ZYNERBA PHARMACEUTICALS, INC. lease, cost for fiscal 2022 was $303.31K, a 0.58% decline from fiscal 2021.
- ZYNERBA PHARMACEUTICALS, INC. lease, cost for fiscal 2021 was $305.07K, a 3.32% decline from fiscal 2020.
- ZYNERBA PHARMACEUTICALS, INC. lease, cost for fiscal 2020 was $315.53K, a 5.13% increase from fiscal 2019.
- ZYNERBA PHARMACEUTICALS, INC. lease, cost for fiscal 2019 was $300.14K.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2023-06-30 | $75.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $160.95K 10-Q · filed 2023-08-14 | $236.04K derived: sum of 3 quarters · filed 2023-08-14 | $311.14K derived: sum of 4 quarters · filed 2023-08-14 |
| 2023-03-31 | $85.85K 10-Q · filed 2023-05-15 | $160.95K derived: sum of 2 quarters · filed 2023-05-15 | $236.04K derived: sum of 3 quarters · filed 2023-05-15 | $311.14K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-12-31 | $75.09K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $150.19K derived: sum of 2 quarters · filed 2023-03-28 | $225.28K derived: sum of 3 quarters · filed 2023-08-14 | $303.31K 10-K · filed 2023-03-28 |
| 2022-09-30 | $75.09K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $150.19K derived: sum of 2 quarters · filed 2023-08-14 | $228.21K 10-Q · filed 2022-11-14 | $303.31K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-06-30 | $75.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $153.12K 10-Q · filed 2023-08-14 | $228.21K derived: sum of 3 quarters · filed 2023-08-14 | $303.31K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $78.02K 10-Q · filed 2023-05-15 | $153.12K derived: sum of 2 quarters · filed 2023-05-15 | $228.21K derived: sum of 3 quarters · filed 2023-05-15 | $303.31K derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $75.09K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $150.19K derived: sum of 2 quarters · filed 2023-03-28 | $225.29K derived: sum of 3 quarters · filed 2023-03-28 | $305.07K 10-K · filed 2023-03-28 |
| 2021-09-30 | $75.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $150.19K derived: sum of 2 quarters · filed 2022-11-14 | $229.98K 10-Q · filed 2022-11-14 | $308.86K derived: sum of 4 quarters · filed 2023-03-28 |
| 2021-06-30 | $75.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $154.88K 10-Q · filed 2022-08-10 | $233.76K derived: sum of 3 quarters · filed 2023-03-28 | $312.65K derived: sum of 4 quarters · filed 2023-03-28 |
| 2021-03-31 | $79.79K 10-Q · filed 2022-05-16 | $158.67K derived: sum of 2 quarters · filed 2023-03-28 | $237.55K derived: sum of 3 quarters · filed 2023-03-28 | $316.44K derived: sum of 4 quarters · filed 2023-03-28 |
| 2020-12-31 | $78.88K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $157.77K derived: sum of 2 quarters · filed 2023-03-28 | $236.65K derived: sum of 3 quarters · filed 2023-03-28 | $315.53K 10-K · filed 2023-03-28 |
| 2020-09-30 | $78.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $157.77K derived: sum of 2 quarters · filed 2021-11-15 | $236.65K 10-Q · filed 2021-11-15 | $314.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $78.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $157.77K 10-Q · filed 2021-08-09 | $235.11K derived: sum of 3 quarters · filed 2022-03-01 | $309.38K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $78.88K 10-Q · filed 2021-05-12 | $156.23K derived: sum of 2 quarters · filed 2022-03-01 | $230.49K derived: sum of 3 quarters · filed 2022-03-01 | $304.76K derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $77.34K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $151.61K derived: sum of 2 quarters · filed 2022-03-01 | $225.88K derived: sum of 3 quarters · filed 2022-03-01 | $300.14K 10-K · filed 2022-03-01 |
| 2019-09-30 | $74.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $148.53K derived: sum of 2 quarters · filed 2020-11-09 | $222.80K 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $74.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $148.53K 10-Q · filed 2020-08-10 | ||
| 2019-03-31 | $74.27K 10-Q · filed 2020-05-11 |